InVitro International Valuation
Is IVRO undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of IVRO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate IVRO's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate IVRO's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for IVRO?
Other financial metrics that can be useful for relative valuation.
What is IVRO's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$1.36m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.3x |
Enterprise Value/EBITDA | -10.5x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does IVRO's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 0.6x | ||
SDCC.Q SmileDirectClub | 0.001x | 11.6% | US$1.8m |
PCYN Procyon | 0.4x | n/a | US$1.8m |
VYCO Vycor Medical | 1.9x | n/a | US$2.7m |
SIEN.Q Sientra | 0.007x | n/a | US$597.9k |
IVRO InVitro International | 1.7x | n/a | US$1.4m |
Price-To-Sales vs Peers: IVRO is expensive based on its Price-To-Sales Ratio (1.7x) compared to the peer average (0.6x).
Price to Earnings Ratio vs Industry
How does IVRO's PE Ratio compare vs other companies in the US Medical Equipment Industry?
Price-To-Sales vs Industry: IVRO is good value based on its Price-To-Sales Ratio (1.7x) compared to the US Medical Equipment industry average (3.4x).
Price to Sales Ratio vs Fair Ratio
What is IVRO's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 1.7x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate IVRO's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.